Svend E. Møller

805 total citations
40 papers, 647 citations indexed

About

Svend E. Møller is a scholar working on Psychiatry and Mental health, Pharmacology and Biological Psychiatry. According to data from OpenAlex, Svend E. Møller has authored 40 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Psychiatry and Mental health, 14 papers in Pharmacology and 14 papers in Biological Psychiatry. Recurrent topics in Svend E. Møller's work include Tryptophan and brain disorders (14 papers), Treatment of Major Depression (14 papers) and Bipolar Disorder and Treatment (13 papers). Svend E. Møller is often cited by papers focused on Tryptophan and brain disorders (14 papers), Treatment of Major Depression (14 papers) and Bipolar Disorder and Treatment (13 papers). Svend E. Møller collaborates with scholars based in Denmark and Sweden. Svend E. Møller's co-authors include Laura Kirk, Paul Rolan, Frank Larsen, Jan Jesper Andreasen, Ole Gredal, Niels Juel Christensen, Ebbe Eldrup, Bjarne Fjalland, Leif Breum and H. E. Høpfner Petersen and has published in prestigious journals such as Analytical Biochemistry, Journal of Chromatography A and Psychological Medicine.

In The Last Decade

Svend E. Møller

40 papers receiving 600 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Svend E. Møller Denmark 17 230 222 210 189 101 40 647
Eric Eccleston United Kingdom 10 215 0.9× 265 1.2× 198 0.9× 269 1.4× 92 0.9× 11 750
Alexander Nies United States 14 156 0.7× 113 0.5× 228 1.1× 218 1.2× 34 0.3× 23 739
Tatjana Dose Germany 7 196 0.9× 177 0.8× 174 0.8× 83 0.4× 124 1.2× 10 658
Alexa J.M. Sorant United States 10 367 1.6× 243 1.1× 262 1.2× 260 1.4× 162 1.6× 20 1.0k
David Nutt United Kingdom 7 184 0.8× 80 0.4× 120 0.6× 173 0.9× 43 0.4× 10 541
Burton J. Goldstein United States 14 242 1.1× 57 0.3× 233 1.1× 198 1.0× 41 0.4× 47 755
Rosa Catalán Spain 16 258 1.1× 182 0.8× 283 1.3× 281 1.5× 147 1.5× 29 866
Meltzer Hy United States 17 81 0.4× 120 0.5× 377 1.8× 269 1.4× 42 0.4× 48 760
Georg Nikisch Germany 12 99 0.4× 130 0.6× 146 0.7× 203 1.1× 193 1.9× 17 588
Shinn‐Won Lim South Korea 11 269 1.2× 241 1.1× 254 1.2× 301 1.6× 108 1.1× 27 817

Countries citing papers authored by Svend E. Møller

Since Specialization
Citations

This map shows the geographic impact of Svend E. Møller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Svend E. Møller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Svend E. Møller more than expected).

Fields of papers citing papers by Svend E. Møller

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Svend E. Møller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Svend E. Møller. The network helps show where Svend E. Møller may publish in the future.

Co-authorship network of co-authors of Svend E. Møller

This figure shows the co-authorship network connecting the top 25 collaborators of Svend E. Møller. A scholar is included among the top collaborators of Svend E. Møller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Svend E. Møller. Svend E. Møller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Møller, Svend E., Frank Larsen, Azhar Khan, & Paul Rolan. (2001). Lack of Effect of Citalopram on the Steady-State Pharmacokinetics of Carbamazepine in Healthy Male Subjects. Journal of Clinical Psychopharmacology. 21(5). 493–499. 19 indexed citations
2.
Møller, Svend E.. (2001). Nutrients and Affective Disorders. PubMed. 5. 135–152. 1 indexed citations
3.
Eldrup, Ebbe, Erik A. Richter, Merete Lund Hetland, et al.. (1997). Origin and Significance of Plasma Dihydroxyphenylalanine. Advances in pharmacology. 42. 851–854. 1 indexed citations
4.
Gredal, Ole, et al.. (1996). Cerebrospinal fluid from amyotrophic lateral sclerosis has no effect on intracellular free calcium in cultured cortical neurons. Molecular and Chemical Neuropathology. 29(2-3). 141–152. 10 indexed citations
5.
Møller, Svend E., et al.. (1996). Aggression and personality: association with amino acids and monoamine metabolites. Psychological Medicine. 26(2). 323–331. 43 indexed citations
6.
Møller, Svend E., et al.. (1996). Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle. European Journal of Clinical Pharmacology. 50(3). 179–184. 22 indexed citations
7.
Gredal, Ole & Svend E. Møller. (1995). Effect of branched-chain amino acids on glutamate metabolism in amyotrophic lateral sclerosis. Journal of the Neurological Sciences. 129(1). 40–43. 9 indexed citations
8.
Møller, Svend E., et al.. (1995). Tyrosine metabolism in users of oral contraceptives. Life Sciences. 56(9). 687–695. 7 indexed citations
9.
Møller, Svend E.. (1993). Plasma amino acid profiles in relation to clinical response to moclobemide in patients with major depression. Journal of Affective Disorders. 27(4). 225–231. 9 indexed citations
10.
Møller, Svend E.. (1993). Quantification of physiological amino acids by gradient ion-exchange high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 613(2). 223–230. 27 indexed citations
11.
Møller, Svend E.. (1992). Serotonin, Carbohydrates, and Atypical Depression. Pharmacology & Toxicology. 71(s1). 61–71. 42 indexed citations
12.
Nielsen, Otto Anker, J. Petersen, Thomas Larsen, et al.. (1991). Paroxetine and imipramine treatment of depressive patients in a controlled multicentre study with plasma amino acid measurements. Acta Psychiatrica Scandinavica. 84(3). 233–241. 23 indexed citations
13.
Møller, Svend E.. (1990). 5-HT uptake inhibitors and tricyclic antidepressants: relation between trytophan availability and clinical response in depressed patients. European Neuropsychopharmacology. 1(1). 41–44. 7 indexed citations
14.
Møller, Svend E., Per Bech, L. F. Gram, et al.. (1990). Plasma ratio trytophan/neutral amino acids in relation to clinical response to paroxetine and clomipramine in patients with major depression. Journal of Affective Disorders. 18(1). 59–66. 25 indexed citations
15.
Møller, Svend E., et al.. (1988). Serotonin reuptake-inhibitor in the treatment of dementia. Nordisk Psykiatrisk Tidsskrift. 42(6). 533–535. 2 indexed citations
16.
17.
Møller, Svend E., et al.. (1986). Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. Psychopharmacology. 88(1). 96–100. 37 indexed citations
18.
Møller, Svend E., et al.. (1983). Tryptophan and tyrosine ratios to neutral amino acids in endogenous depression. Journal of Affective Disorders. 5(1). 67–79. 20 indexed citations
19.
Møller, Svend E., et al.. (1979). Free and total plasma tryptophan in endogenous depression. Journal of Affective Disorders. 1(1). 69–76. 26 indexed citations
20.
Møller, Svend E., et al.. (1975). Plasma aminosyre mønstret hos manio-depressive patienter. Nordisk Psykiatrisk Tidsskrift. 29(6). 461–462. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Eccleston Breakdown of academic impact, for papers by Alexander Nies Breakdown of academic impact, for papers by Tatjana Dose Breakdown of academic impact, for papers by Alexa J.M. Sorant Breakdown of academic impact, for papers by David Nutt Breakdown of academic impact, for papers by Burton J. Goldstein Breakdown of academic impact, for papers by Rosa Catalán Breakdown of academic impact, for papers by Meltzer Hy Breakdown of academic impact, for papers by Georg Nikisch Breakdown of academic impact, for papers by Shinn‐Won Lim
Rankless by CCL
2026